Systematic review of foam sclerotherapy for varicose veins

British Journal of Surgery

Volumn 94, Issue 8, 2007, Pages 925-936

  Jia, X ^a   Mowatt, G ^a   Burr, J M ^a   Cassar, K ^b   Cook, J ^a   Fraser, C ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; HEADACHE; HUMAN; LUNG EMBOLISM; META ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCLEROTHERAPY; SKIN PIGMENTATION; SYSTEMATIC REVIEW; THROMBOPHLEBITIS; VARICOSIS; VISUAL DISORDER;

HUMANS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; SCLEROTHERAPY; TREATMENT OUTCOME; VARICOSE VEINS;

EID: 34547782295     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5891     Document Type: Review

References (77)

1. Orbach EJ. Contributions to the therapy of the varicose complex. J Int Coll Surg 1950; 29: 765-771.
2. Cabrera Garrido J, Cabrera Garcia-Olmedo JR, Garcia-Olmedo Dominguez MA. Elargissement des limites de la sclerotherapie: nouveaux produits sclerosants. Phlebologie 1997; 50: 181-188.
3. Monfreux A. Treatement sclerosant des troncs sapheneis et leurs collaterales e gros calibre par la methode MUS. Phlebologie 1997; 50: 351-353.
4. Tessari L. Nouvelle technique d'obtention de la sclero-mousse. Phlebologie 2000; 53: 129-133.
5. Nicolaides AN, members of the Executive Committee. Classification and grading of chronic venous disease in the lower limbs: a consensus statement. In Handbook of Venous Disorders, Gloviczki P, Yao JST (eds). Chapman & Hall Medical: London, 1996; 652-660.
6. Alos J, Carreno P, Lopez JA, Estadella B, Serra-Prat M, Marinel-Lo J. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 2006; 31: 101-107.
7. Belcaro G, Cesarone MR, Di Renzo A, Brandolini R, Coen L, Acerbi G et al. Foam-sclerotherapy, surgery, sclerotherapy, and combined treatment for varicose veins: a 10-year, prospective, randomized, controlled, trial (VEDICO trial). Angiology 2003; 54: 307-315.
8. Bountouroglou DG, Azzam M, Kakkos SK, Pathmarajah M, Young P, Geroulakos G. Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomised controlled trial. Eur J Vasc Endovasc Surg 2006; 31: 93-100.
9. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003; 29: 1170-1175.
10. Kern P, Ramelet AA, Wutschert R, Bounameaux H, Hayoz D. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectaric leg veins. Dermatol Surg 2004; 30: 367-372.
11. Rao J, Wildemore JK, Goldman MP. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg 2005; 31: 631-635.
12. Wright D, Gobin JP, Bradbury AW, Coleridge-Smith P, Spoelstra H, Berridge D et al. Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology 2006; 21: 180-190.
13. Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12 173 sclerotherapy sessions. Dermatol Surg 2005; 3: 123-128.
14. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 2004; 30: 718-722.
15. Barren: JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm. Dermatol Surg 2004; 30: 1386-1390.
16. Bergan J, Pascarella L, Mekenas L. Venous disorders: treatment with sclerosant foam. J Cardiovasc Surg (Torino) 2006; 47: 9-18.
17. Cabrera J, Redondo P, Becerra A, Garrido C, Cabrera J Jr, Garcia-Olmedo MA et al. Ultrasound-guided injection of polidocanol microfoam in the management of venous leg ulcers. Arch Dermatol 2004; 140: 667-673.
18. Cabrera J, Cabrera J Jr, Garcia-Olmedo MA. Sclerosants in microfoam. A new approach in angiology. Int Angiol 2001; 20: 322-329.
19. Cavezzi A, Frullini A, Ricci S, Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 2002; 17: 13-18.
20. Cavezzi A, Frullini A. The role of sclerosing foam in ultrasound guided sclerotherapy of the saphenous veins and of recurrent varicose veins: our personal experience. Aust N Z J Phlebol 1999; 3: 49-50.
21. Coleridge-Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg 2006; 32: 577-583.
22. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 2002; 28: 11-15.
23. Hamada T, El Hamid MA. Foam treatment for varicose veins; efficacy and safety. Scientific Medical Journal 2006; 18: 1-14.
24. Kakkos SK, Bountouroglou DG, Azzam M, Kalodiki E, Daskalopoulos M, Geroulakos G. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results. J Endovasc Ther 2006; 13: 357-364.
25. McDonagh B, Huntley DE, Rosenfeld R, King T, Harry JL, Sorenson S et al. Efficacy of the comprehensive objective mapping, precise image guided injection, anti-reflux positioning and sequential sclerotherapy (COMPASS) technique in the management of greater saphenous varicosities with saphenofemoral incompetence. Phlebology 2002; 17: 19-28.
26. Padbury A, Benveniste GL. Foam echosclerotherapy of the small saphenous vein. Aust N Z J Phlebol 2004; 8: 5-8.
27. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27: 58-60.
28. de Waard MM, der Kinderen DJ. Duplex ultrasonography-guided foam sclerotherapy of incompetent perforator veins in a patient with bilateral venous leg ulcers. Dermatol Surg 2005; 31: 580-583.
29. Lloret P, Redondo P, Sierra A, Cabrera J. Mixed skin ulcers misdiagnosed as pyoderma gangrenosum and rheumatoid ulcer: successful treatment with ultrasound-guided injection of polidocanol microfoam. Dermatol Surg 2006; 32: 749-752.
30. van Neer PA. Perforans varicosis: treatment of the incompetent perforating vein is important. Dermatol Surg 2004; 30: 754-755.
31. Weaver PR. Recurrent scintillating scotomata precipitated by sclerotherapy. Aust N Z J Phlebol 2004; 8: 9-10.
32. Martimbeau PR. A randomized clinical trial comparing the effects of foam vs liquid formulas for sclerotherapy of primary varicose veins. Perfluoropropane-filled albumin microspheres-sodium tetradecyl sulfate vs air-filled sodium tetradecyl sulfate for foam sclerotherapy of great saphenous vein incompetence. International Union of Phlebology, UIP World Congress, American Chapter Meeting, San Diego, 2003.
33. Rybak Z. Aethoxysclerol foam obliteration of insufficient perforating veins in patients suffering from leg ulcers: a clinical recommentation. International Union of Phlebology, UIP World Congress Chapter Meeting, San Diego, 2003.
34. Chung JK, Chung IM, Kim SJ. Foam sclerotherapy in telangiectatic leg veins. International Union of Phlebology, UIP World Congress, American Chapter Meeting, San Diego, 2003.
35. Gobin JP. French experience with Varisolve PD microfoam in the management of moderate to severe varicose veins. International Union of Phlebology, UIP World Congress, American Chapter Meeting, San Diego, 2003.
36. Gonzalez R. Foam closure of the long saphenous vein: preliminary report. International Union of Phlebology, UIP World Congress, American Chapter Meeting, San Diego, 2003.
37. Grondin L. Foam echosclerotherapy of incompetent saphenous veins. Phlebolymphology 2003; 42: S24.
38. Grondin L. Foam echo-sclerotherapy of incompetent saphenous veins. International Union of Phlebology, UIP World Congress, American Chapter Meeting, San Diego, 2003.
39. Baker SJ, Darke SG. Ultrasound guided foam sclerotherapy (UGFS) early outcome of treatment in 220 limbs. Br J Surg 2006; 93(Suppl 1): 92 (Abstract).
40. Bhowmick A, Harper D, Wright D, McCollum CN. Polidocanol microfoam sclerotherapy for long saphenous varicose veins. Phlebology 2001; 16: 41-50.
41. Cavezzi A. Combination of phlebectomy and duplex-guided foam sclerotherapy. International Union of Phlebology, UIP World Congress, American Chapter Meeting, San Diego, 2003.
42. Coleridge-Smith P. Compression implication of large vein sclerotherapy with sclerosant foam. International Union of Phlebology, UIP World Congress, American Chapter Meeting, San Diego, 2003.
43. Forlee MV, Dowdall JF, Haider SN, McDonnell CO, Nyheim T, Malik V et al. Foam injection sclerotherapy cures veins with a single injection: fact or fiction? Seventh Annual Meeting of the European Venous Forum, London, 2006; paper 5.24.
44. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006; 43: 162-164.
45. Frullini A. Duplex-guided sclerotherapy of cavernoma. 14th International Union of Phlebology, UIP World Congress, Rome, 2001.
46. Gonzalez R, Barahona-Cruz S. Clinical and hemodynamic outcomes of duplex-guided foam sclerotherapy: a 24 month follow-up study. 15th International Union of Phlebology, UIP World Congress, Rio de Janeiro, 2005.
47. Mackay E. Combination therapy for the treatment of recurrent varicose veins after ligation and stripping using transcatheter sclerotherapy, endovenous laser and phlebectomy. American College of Phlebology, 16th Annual Congress, Fort Lauderdale, 2002.
48. McCollum C, Harper D. UK experience with Varisolve polidocal microfoam. 14th International Union of Phlebology, UIP World Congress, Rome, 2001.
49. Morrison N, Rogers C, Neuhardt D, Melfy K. Large-volume, ultrasound guided polidocanol foam sclerotherapy: a prospective study of toxicity and complications. International Union of Phlebology, UIP World Congress, American Chapter Meeting, San Diego, 2003.
50. Nitecki S, Bass A. Short-term results of ultrasound-guided sclerotherapy for venous insufficiency. Phlebology 2005; 20: 155.
51. Sadoun S. Long-term follow-up study of ultrasound findings in varicose greater saphenous veins treated with foam. International Union of Phlebology, UIP World Congress, American Chapter Meeting, San Diego, 2003.
52. Schadeck M. Sclerotherapy: comparison of techniques. Introductory lecture: state of the art. 14th International Union of Phlebology, UIP World Congress, Rome, 2001.
53. Sierra A, Redondo P, Cabrera J, Cabrera J Jr, Garcia-Olmedo MA. Large volume microfoam therapy for recurrent variscose veins. American College of Phlebology, 16th Annual Congress, Fort Lauderdale, 2002.
54. Tessari L. Trans-catheter (short or long) foam sclerotherapy in the treatment of varicose veins. Phlebology 2004; 19: 150-151.
55. Vin F. Indications and outcome of greater saphenous vein foam sclerotherapy. 15th International Union of Phlebology, UIP World Congress, Rio de Janeiro, 2005.
56. Weiss R, Weiss MA. Observations on the use of foamed sodium tetradecyl sulfate for treatment of telangiectasias and reticular veins. American College of Phlebology, 16th Annual Congress, Fort Lauderdale, 2002.
57. Benigni J, Sadoun S, Thirion V, Sica M, Demagny A, Chahim M. [Telangiectases and reticular veins treatment with a 0,25% aetoxisclerol foam presentation of a pilot study.] Phlebologie 1999; 52: 283-290.
58. Demagny A. Comparative study into the efficacy of a sclerosant product in the form of liquid or foam in echo-guided sclerosis of the arches of the long and short saphenous veins. Phlebologie 2002; 55: 133-137.
59. Breu FX, Marshall M, Guggenbichler S. Prospective study on foam sclerotherapy. Vasomed 2004; 16: 133.
60. Creton D. Sclerotherapie a la mousee dans les recidives après chirurgie. Séance de la Societe Francaise de Phlebologi, La sclerotherapie a la mousse en pratique, http://www.sF-phlebologie.org/cr. php., 2005.
61. Ferrara F, Bernach HR. Needle-size and efficacy of foam sclerotherapy. Phlebologie 2005; 58: 229-234.
62. Frullini A, Cavezzi A. Echosclerosis using sodium tetradecyl-sulphate and polidocanol foam: two years experience. Phlebologie 2000; 53: 431-435.
63. Hamel-Desnos C, Allaert FA, Benigni J, Boitelle G, Chleir F, Ouvry P et al. Study 3/j.polidocanol foam 3% versus 1% in the great saphenous vein: early results. Phlebologie 2005; 58: 175-182.
64. Lucchi M, Bilancini S, Tucci S. Sclerosis of the great saphenous vein: short term results. Phlebologie 2003; 56: 389-394.
65. Milleret R, Garandeau C, Brel D, Allaert FA. Foam sclerotherapy of the great saphenous veins via ultrasound-guided catheter in an empty vein: the alpha-technique. Phlebologie 2004; 57: 15-18.
66. Schadeck M. [Sclerotherapy of the small saphenous vein: how to avoid bad results?] Phlebologie 2004; 57: 165-169.
67. Sica M. Echoguided sclerotherapy with 1% trombovar foam via short endovenous catheter (m.s.method): results. Phlebologie 2005; 58: 161-174.
68. Sica M. Treatment of varices greater than 8 mm in diameter with foam echosclerotherapy and compression. Phlebologie 2003; 56: 139-145.
69. Stucker M, Hermes N, Altmeyer P. A pilot study: safety and effectiveness of periulcerous foam sclerotheraphy. Vasomed 2005; 17: 138.
70. Uhl JF, Creton D. La sclerotherapi a la moussemau cours de la chirurgie des varices: indications et resultats. Séance de la Societe Francaise de Phlebologi, La sclerotherapie a la mousse en pratique, 2005.
71. Wildenhues B. Catheter-assisted foam sclerotherapy: a new minimally-invasive method for the treatment of trunk varicosis of the long and short saphenous veins. Phlebologie 2005; 34: 165-170.
72. Benigni J, Ratinahirana H. Polidocanol foam: migraine with aura. Phlebologie 2005; 58: 289-291.
73. Ceulen RPM, Shadid N, Sommer A. ZonMW foam study: stripping versus duplex guided foam sclerotherapy as treatment for the greater varicose veins. Nederland Tijdschr Dermatol Venereol 2006; 16: 196-197.
74. Fischer DC, Fisher EA, Budd JH, Rosen SE, Goldman ME. The incidence of patent foramen ovale in 1000 consecutive patients. A contrast transesophageal echocardiography study. Chest 1995; 107: 1504-1509.
75. Australasian College of Phlebology. Ultrasound Guided Sclerotherapy. Diagnose Venous Disease and Treat Superficial Venous Incompetence with Injected Sclerosants Under Ultrasound Guidance. Bondi Junction, NSW: Australian College of Phlebology, 2005.
76. Rabe E, Pannier-Fischer F, Gerlach H, Breu FX, Guggenbichler S, Zabel M et al. Guidelines for sclerotherapy of varicose veins (ICD 10: I83.0, I83.1, I83.2, and I83-9). Dermatol Surg 2004; 30: 687-693.
77. Breu FX, Guggenbichler S. European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany. Dermatol Surg 2004; 30: 709-717.